OptimizeRx (OPRX) Depreciation & Amortization (CF) (2016 - 2026)
OptimizeRx's Depreciation & Amortization (CF) history spans 16 years, with the latest figure at $1.1 million for Q4 2025.
- On a quarterly basis, Depreciation & Amortization (CF) fell 1.46% to $1.1 million in Q4 2025 year-over-year; TTM through Dec 2025 was $4.3 million, a 0.07% change, with the full-year FY2025 number at $4.3 million, changed 0.05% from a year prior.
- Depreciation & Amortization (CF) hit $1.1 million in Q4 2025 for OptimizeRx, roughly flat from $1.1 million in the prior quarter.
- Over the last five years, Depreciation & Amortization (CF) for OPRX hit a ceiling of $1.1 million in Q3 2024 and a floor of $385152.0 in Q4 2021.
- Historically, Depreciation & Amortization (CF) has averaged $777289.8 across 5 years, with a median of $792558.0 in 2022.
- Biggest five-year swings in Depreciation & Amortization (CF): fell 19.57% in 2023 and later surged 134.48% in 2024.
- Tracing OPRX's Depreciation & Amortization (CF) over 5 years: stood at $385152.0 in 2021, then rose by 18.54% to $456545.0 in 2022, then soared by 120.57% to $1.0 million in 2023, then rose by 8.64% to $1.1 million in 2024, then fell by 1.46% to $1.1 million in 2025.
- Business Quant data shows Depreciation & Amortization (CF) for OPRX at $1.1 million in Q4 2025, $1.1 million in Q3 2025, and $1.1 million in Q2 2025.